Journal of the National Comprehensive Cancer Network : Jnccn
Overview
The Journal of the National Comprehensive Cancer Network (JNCCN) is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of cancer. It provides comprehensive and up-to-date research, clinical guidelines, and expert insights from renowned oncologists, aiming to improve patient outcomes and promote collaboration among healthcare professionals in the field of oncology.
Details
Details
Abbr.
J Natl Compr Canc Netw
Start
2003
End
Continuing
Frequency
Monthly, 2010-
p-ISSN
1540-1405
e-ISSN
1540-1413
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 1411
150
SJR / Ranks: 361
4102
CiteScore / Ranks: 391
19.00
JIF / Ranks: 272
13.4
Recent Articles
1.
Pang L, Zhuang W, Chen Z, Liao J, Li M, Zhang L, et al.
J Natl Compr Canc Netw
. 2025 Mar;
:1-8.
PMID: 40081325
Background: Traditional chemotherapy provides restricted benefits for advanced EGFR-mutant non-small cell lung cancer (NSCLC) after failure of EGFR-tyrosine kinase inhibitors (EGFR-TKIs), necessitating the combined treatment. However, it remains controversial which...
2.
Shen C, Du Y, Xiang S, Li Z, Liu C, Liu Z, et al.
J Natl Compr Canc Netw
. 2025 Mar;
:1-8.
PMID: 40081320
Background: The current AJCC TNM staging system for medullary thyroid cancer (MTC) is largely adapted from criteria for differentiated thyroid cancer, which may not fully capture MTC-specific prognostic factors. This...
3.
Wen D, Jin J, Lin J, Luo M, Liu R, Liu S, et al.
J Natl Compr Canc Netw
. 2025 Mar;
:1-9.
PMID: 40081316
Background: Chemotherapy combined with immunotherapy (CT-IO) has become the first-line treatment for de novo metastatic nasopharyngeal carcinoma (dmNPC). Locoregional radiotherapy (LRRT) following chemotherapy has been shown to significantly improve survival...
4.
Gajjar A, Mahajan A, Bale T, Bowers D, Canan L, Chi S, et al.
J Natl Compr Canc Netw
. 2025 Mar;
23(3):113-130.
PMID: 40073837
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Central Nervous System Cancers provide multidisciplinary diagnostic workup, staging, and treatment recommendations for diffuse high-grade gliomas and medulloblastomas in...
5.
6.
Greenberg P, Stone R, Abaza Y, Al-Kali A, Anand S, Ball B, et al.
J Natl Compr Canc Netw
. 2025 Mar;
23(3):66-75.
PMID: 40073835
The NCCN Guidelines for Myelodysplastic Syndromes (MDS) provide recommendations for the evaluation, diagnosis, and comprehensive care of patients with MDS based on a review of recent clinical evidence that has...
7.
Narkhede M, Ujjani C
J Natl Compr Canc Netw
. 2025 Mar;
23(3).
PMID: 40073834
Infectious complications are among the leading causes of mortality in chronic lymphocytic leukemia (CLL). Over the past decade, several advances have been made in treating CLL through inhibition of Bruton...
8.
Patell R, Bindal P, Freed J, Dodge L, Nagaraj G, LaCasce A, et al.
J Natl Compr Canc Netw
. 2025 Mar;
23(3):82-89.
PMID: 40073833
Background: Oncology providers often lack the confidence to make clinical recommendations about medical cannabis (MC). This study aimed to develop and evaluate the feasibility of implementing an educational curriculum on...
9.
Jiang S, Patel V, Stabellini N, Datta B, Nain P, Seth L, et al.
J Natl Compr Canc Netw
. 2025 Mar;
:1-9.
PMID: 40073832
Background: Rural areas have higher cardiovascular disease (CVD) incidence and age-adjusted mortality rates in the general population. However, the impact of rurality on CVD development and outcomes in patients with...
10.
Boman C, Tranchell C, Liu X, Eriksson Bergman L, Toli M, Bergh J, et al.
J Natl Compr Canc Netw
. 2025 Mar;
:1-7.
PMID: 40073831
Background: Pathologic complete response (pCR) following neoadjuvant chemotherapy (NACT) for early-stage breast cancer is prognostic, but not the sole surrogate marker for long-term outcome at a trial level, given that...